Camonsertib (RP-3500) is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. Camonsertib shows 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kalpha kinases. Camonsertib has potent antitumor activity[1].
Molekulargewicht:
410.47
Reinheit:
99.99
CAS Nummer:
[2417489-10-0]
Formel:
C21H26N6O3
Target-Kategorie:
ATM/ATR,mTOR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten